tiprankstipranks
Protalix Biotherapeutics (DE:PBDA)
FRANKFURT:PBDA
Germany Market
PBDA
Protalix
RESEARCH TOOLSreports

Protalix (PBDA) Income Statement

0 Followers

Protalix Income Statement

Last quarter (Q2 2026), Protalix's total revenue was $19.90M, an increase of 27.07% from the same quarter last year. In Q2, Protalix's net income was $3.78M. See Protalix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 52.74M$ 53.40M$ 65.49M$ 47.64M$ 38.35M
Gross Profit
$ 25.24M$ 29.08M$ 42.51M$ 28.05M$ 22.00M
Operating Expenses
$ 30.74M$ 25.16M$ 32.05M$ 41.06M$ 42.46M
Depreciation and Amortization
$ 1.47M$ 1.30M$ 1.19M$ 1.09M$ 1.12M
EBITDA
$ -2.95M$ 6.52M$ 12.94M$ -10.78M$ -18.94M
Operating Income
$ -5.50M$ 3.92M$ 10.46M$ -13.01M$ -20.46M
Other Income/Expenses
$ -108.00K$ 237.00K$ -1.89M$ -1.38M$ -7.12M
Pretax Income
$ -5.61M$ 4.15M$ 8.57M$ -14.40M$ -27.58M
Net Income
$ -6.60M$ 2.93M$ 8.31M$ -14.93M$ -27.58M
Per Share Metrics
Basic EPS
$ -0.08$ 0.04$ 0.12$ -0.31$ -0.62
Diluted EPS
$ -0.08$ 0.04$ 0.10$ -0.31$ -0.62
Weighted Average Shares Outstanding
 78.55M 72.53M 67.51M 48.47M 44.14M
Weighted Average Shares Outstanding (Diluted)
 78.55M 81.06M 82.42M 48.47M 44.14M
Currency in USD

Protalix Earnings and Revenue History